FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

MPRX, Inc. dba Medical Park Pharmacy Finasteride/Biotin 1 mg/50 mcg Recall

Finasteride/Biotin 1 mg/50 mcg

MPRX, Inc. dba Medical Park Pharmacy · Dallas, TX

Risk level
Class II
Reported by FDA
Feb 5, 2020
Recall ID
D-0804-2020
Check your lot numberHow we source this data

Summary

MPRX, Inc. dba Medical Park Pharmacy recalled Finasteride/Biotin 1 mg/50 mcg starting Dec 18, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0804-2020 on Feb 5, 2020. Reason: Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components. Status: Terminated.

Why it was recalled

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

Product description

Finasteride/Biotin 1 mg/50 mcg

Lot numbers, UPCs & expiration codes

Lot: 60658:42 Use by: 12/28/2019

Where it was sold

TX

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0804-2020
Classification
Class II
Status
Terminated
Recall initiated
Dec 18, 2019
FDA report date
Feb 5, 2020
Quantity
1 bottle
Recall type
Voluntary: Firm initiated
Recalling firm
MPRX, Inc. dba Medical Park Pharmacy

Original FDA data

Every field from FDA enforcement report D-0804-2020, exactly as published.

Show all FDA fields
City
Dallas
State
TX
Status
Terminated
Country
United States
Event ID
84527
Address
8230 Elmbrook Dr Ste 600b
Code information
Lot: 60658:42 Use by: 12/28/2019
Postal code
75247-4144
Report date
Feb 5, 2020
Product type
Drugs
Recall number
D-0804-2020
Classification
Class II
Recalling firm
MPRX, Inc. dba Medical Park Pharmacy
Product quantity
1 bottle
Termination date
Dec 13, 2022
Reason for recall
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Finasteride/Biotin 1 mg/50 mcg
Distribution pattern
TX
Recall initiation date
Dec 18, 2019
Initial firm notification
Letter
Center classification date
Jan 29, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0804-2020, published Feb 5, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls